3-(4-Bromo-2,5-difluoro-phenyl)oxetan-3-ol, 98%, 100mg

Ethyl 2,4-dichloro-5-fluorobenzoate, 98%, 250mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-iodobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 1g

D-Mannopyranose, pentabenzoate, 97%, 5g

2-Methoxy-4-phenylbenzaldehyde, 96%, 10g

(1,2,3,4-tetrahydro-6-isoquinolinyl)-Carbamic acid, 1,1-dimethylethyl ester, 98%, 500mg

5-Isopropyl-1-(pyridin-2-yl)-1h-pyrazole-3-carboxylic acid, 95%, 250mg

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.22 μm, 500 ml, 1000 ml, 12 Piece(s)

3-Chloro-[1,1'-biphenyl]-4-carbonitrile, 95.0%, 1g

(2R,5S)-2,5-Dimethylmorpholine, 98+%, 100mg

Methyl 2-(2-bromo-3-chlorophenyl)acetate, 95%, 10g

N-(2,2,2-trifluoroethyl)pyridin-2-amine, 95.0%, 100mg

Phenylcyclohexane>97.0%(GC)100mL